Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats.
D000818:Animals; D002452:Cell Count; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D007668:Kidney / Q000382:microbiology; D009268:Nalidixic Acid / Q000627:therapeutic use*; D009582:Nitrofurantoin / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000188:drug therapy*; D051381:Rats; D013752:Tetracycline / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009268:Nalidixic Acid; D009582:Nitrofurantoin; D013752:Tetracycline; D010118:Oxytetracycline